Rino Seedor - Thomas Jefferson University

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 25 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Meeting Report from the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 2023

Rino S. Seedor,Andrew E. Aplin, Corine Bertolotto,Richard D. Carvajal, Nigel Deacon, Katie Doble,Omid Hamid,Rizwan Haq, Miriam Kadosh,Shaheer Khan, Jacqueline Kraska, Jose Lutzky,Meredith McKean,Kamaneh Montazeri,Justin Moser,Michael Onken,Marlana Orloff,Joseph J. Sacco, Keiran Smalley,Sara M. Selig

PIGMENT CELL & MELANOMA RESEARCH（2024）

引用0浏览0WOS引用

A Phase 3 Trial of IMC-F106C (PRAME X CD3) Plus Nivolumab Versus Standard Nivolumab Regimens in HLA-A*02:01+ Patients with Previously Untreated Advanced Melanoma (PRISM-MEL-301)

Georgina V. Long,Victoria Atkinson,Paolo A. Ascierto,Diwakar Davar,Omid Hamid,Caroline Robert,Marcus O. Butler,Reinhard Dummer,Christine Hafner,Muhammad A. Khattak,James Larkin,Paul Lorigan,Meredith McKean,Rino S. Seedor,Heather Shaw,Joe Stephenson, Yuan, Roma Patel,Piruntha Thiyagarajah,Dirk Schadendorf

Journal of clinical oncologyno. 16_suppl (2024): TPS9602-TPS9602

引用0浏览0引用

Geospatial Analysis of the Distribution of Uveal Melanoma Patients at a Referral Center in the United States

Rino S. Seedor,Daniel T. Vader, Renee H. Moore, Alexandre J. Motta, Sara E. Lally,Carol L. Shields,Takami Sato,Marlana M. Orloff

Journal of Clinical Oncologyno. 16_suppl (2024): e21566-e21566

引用0浏览0引用

Real World Tebentafusp-Tebn Experience at a Tertiary Care Referral Center

Allison Gradone,Rino S. Seedor,Takami Sato, Jessica Hilly, Erin Sharpe-Mills, Madeleine Naccarato, Mindy Chen,Marlana M. Orloff

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

A Phase 3 Trial of IMC-F106C (PRAME X CD3) Plus Nivolumab Versus Standard Nivolumab Regimens in HLA-A*02:01+patients with Previously Untreated Advanced Melanoma (PRISM-MEL-301)

Georgina V. Long,Victoria Atkinson,Paolo Antonio Ascierto,Diwakar Davar,Omid Hamid,Caroline Robert, Marcus O. Butler,Reinhard Dummer,Christine Hafner, Muhammad Adnan Khattak,James Larkin,Paul Lorigan,Meredith McKean,Rino S. Seedor,Heather May Shaw, Joe Stephenson, Yuan, Roma Patel, Piruntha Thiyagarajah,Dirk Schadendorf

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Abstract CT260: A phase II trial of defactinib combined with avutometinib in patients with metastatic uveal melanoma

Rino S. Seedor,Mizue Terai, Amry Majeed,Ryota Tanaka,Andrew E. Aplin,Marlana Orloff,Alfredo A. Molinolo,J Silvio Gutkind,Takami Sato

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Preapproval Medical Products in Patients with the Diagnosis of Metastatic Uveal Melanoma

Regine Nshimiyimana Maniraho,Rino S. Seedor,Lisa Kearns,Alison Bateman-House,Marlana M. Orloff,Scott W. Keith,Katherine Senter,Takami Sato

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Quality-of-life Measurement in High-Risk Patients with Uveal Melanoma Receiving Adjuvant Sunitinib or Valproic Acid

Regine Nshimiyimana Maniraho,Scott W. Keith,Marlana M. Orloff,Rino S. Seedor, Leah Downie,Liam Hulse,Shingo Sato,Erin Sharpe-Mills,Takami Sato

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

A Phase 2/3 Trial in Progress on Tebentafusp As Monotherapy and in Combination with Pembrolizumab in HLA-A*02:01+patients with Previously Treated Advanced Non-Uveal Melanoma (TEBE-AM)

Diwakar Davar,Alexandra Ikeguchi,Elizabeth Iannotti Buchbinder,Alexander Noor Shoushtari,Rino S. Seedor,Eric Bernicker,Sarah A. Weiss,Gregory A. Daniels,Timothy J. Panella, Hannah Frances Ryan,Howard Goodall,Ryan J. Sullivan

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn